Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL21980911 | 0.96 | SLC34A1 (0.38) | — | |
| Phosphoric Acid SCHEMBL6653136 | 0.94 | SLC34A1 (0.39) | — | |
| Phosphoric Acid SCHEMBL8075511 | 0.93 | — | — | |
| Phosphoric Acid SCHEMBL28128544 | 0.90 | SLC34A1 (0.41) | — | |
| Phosphoric Acid SCHEMBL1534158 | 0.89 | CA1 (0.33) | — | |
| Phosphoric Acid SCHEMBL937335 | 0.89 | CA1 (0.33) | — | |
| Phosphoric Acid SCHEMBL8003843 | 0.87 | — | — | |
| Phosphoric Acid SCHEMBL21977515 | 0.83 | LMNA (0.35) | — | |
| Phosphoric Acid SCHEMBL5096806 | 0.83 | — | — | |
| Phosphoric Acid SCHEMBL7748933 | 0.83 | SLC34A1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199619-A1 | WEE1 INHIBITOR AND USE THEREOF | JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD. (CN) | 2024-06-20 | — | — | US | disclosed |
| US-20140234916-A1 | METHOD FOR PRODUCING MONATIN USING AN L-AMINO ACID AMINOTRANSFERASE | AJINOMOTO CO., INC. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-8771997-B2 | Method for producing monatin using an L-amino acid aminotransferase | AJINOMOTO CO., INC. (JP) | 2014-07-08 | — | — | US | disclosed |
| US-20120270279-A1 | METHOD FOR PRODUCING MONATIN | AJINOMOTO CO. INC (JP) | 2012-10-25 | — | — | US | disclosed |
| US-20120208244-A1 | METHOD FOR PRODUCING MONATIN | AJINOMOTO CO., INC. (JP) | 2012-08-16 | — | — | US | disclosed |
| EP-0686047-B1 | 5-HT 1A LIGANDS | WYETH JOHN & BROTHER LTD (GB) | 2000-01-12 | — | — | EP | disclosed |
| EP-0686047-A1 | 5-HT 1A? LIGANDS | JOHN WYETH & BROTHER LIMITED (GB) | 1995-12-13 | — | — | EP | disclosed |
| WO-1994019026-A1 | 5-HT1A LIGANDS | JOHN WYETH & BROTHER LIMITED (GB) | 1994-09-01 | — | — | WO | disclosed |
| EP-0274422-B1 | NEW ANTIBIOTIC PRODUCED BY FERMENTATION | Pfizer Limited (GB) | 1993-05-12 | — | — | EP | disclosed |
| US-4920215-A | TREATING SWINE DYSENTERY; GROWTH PROMOTER IN FEEDS | PFIZER INC. (US) | 1990-04-24 | — | — | US | disclosed |
| EP-0274422-A2 | New antibiotic produced by fermentation | Pfizer Limited (GB) | 1988-07-13 | — | — | EP | disclosed |